The Cooper Companies, Inc. logo

The Cooper Companies, Inc. (CP60)

Market Open
5 Dec, 07:13
XFRA XFRA
72. 00
+7.5
+11.63%
- Market Cap
- P/E Ratio
0.12% Div Yield
0 Volume
- Eps
64.5
Previous Close
Day Range
72 72
Year Range
54 99.1
Want to track CP60 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 89 days

Summary

CP60 trading today higher at €72, an increase of 11.63% from yesterday's close, completing a monthly increase of 20% or €12. Over the past 12 months, CP60 stock lost -18.74%.
CP60 pays dividends to its shareholders, with the most recent payment made on Aug 11, 2023. The next estimated payment will be in 11 Aug 2023 on Aug 11, 2023 for a total of €0.0075.
The last earnings report, released on Yesterday at 12:00 AM, missed the consensus estimates by -1.12%. On average, the company has fell short of earnings expectations by -0.37%, based on the last three reports. The next scheduled earnings report is due on Mar 04, 2026.
The Cooper Companies, Inc. has completed 3 stock splits, with the recent split occurring on Feb 20, 2024.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

CP60 Chart

The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript

The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript

The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript

Seekingalpha | 8 hours ago
The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The Cooper Companies (COO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for The Cooper Companies (COO) give insight into how the company performed in the quarter ended October 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 10 hours ago
The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates

The Cooper Companies (COO) Q4 Earnings and Revenues Surpass Estimates

The Cooper Companies (COO) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $1.04 per share a year ago.

Zacks | 11 hours ago

The Cooper Companies, Inc. (CP60) FAQ

What is the stock price today?

The current price is €72.00.

On which exchange is it traded?

The Cooper Companies, Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is CP60.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.12%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Mar 04, 2026.

Has The Cooper Companies, Inc. ever had a stock split?

The Cooper Companies, Inc. had 3 splits and the recent split was on Feb 20, 2024.

The Cooper Companies, Inc. Profile

- Industry
- Sector
Albert G. White III CEO
XFRA Exchange
US2166485019 ISIN
US Country
16,000 Employees
26 Jul 2023 Last Dividend
20 Feb 2024 Last Split
- IPO Date

Overview

The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global entity that specializes in the development, manufacture, and marketing of contact lenses through its subsidiaries. The operations of the company are segmented into CooperVision and CooperSurgical. CooperVision focuses on providing a variety of contact lenses including those for correcting nearsightedness, farsightedness, astigmatism, presbyopia, and myopia across various regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical addresses family and women's health, offering a wide range of fertility products and services, medical devices, contraception, and cryostorage services for cord blood and tissue to healthcare professionals and patients globally. The products offered by The Cooper Companies, Inc. reach their end-users through distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals, clinics, and authorized resellers.

Products and Services

CooperVision:

  • Spherical Lenses: These lenses are designed to correct common vision problems such as nearsightedness and farsightedness.
  • Toric and Multifocal Lenses: These lenses provide solutions for more complex vision challenges, including astigmatism, presbyopia, and myopia, catering to a diverse range of contact lens wearers.

CooperSurgical:

  • Fertility Products and Services: Includes consumables, equipment, donor gamete services, and genomic services such as genetic testing, designed to support the varying needs of fertility treatments.
  • Medical Devices and Contraception: Ranging from Paragard contraceptive IUDs, endosee endometrial imaging, and Mara water ablation systems, these products aim to provide innovative solutions in women's healthcare and family planning.
  • Cryostorage Services: Offering storage solutions for cord blood and tissue, these services play a crucial role in regenerative medicine and future health considerations.
  • Surgical and Office Products: This encompasses a broad spectrum of devices and tools such as illuminated speculum products, lone star retractor systems, and fetal pillow cephalic elevation devices, used across gynecological procedures and office-based diagnostics.

Contact Information

Address: 6101 Bollinger Canyon Road
Phone: 925 460 3600